SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000875320-21-000009
Filing Date
2021-04-20
Accepted
2021-04-20 08:03:42
Documents
14
Period of Report
2021-04-16
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K vrtx-20210416.htm   iXBRL 8-K 37649
  Complete submission text file 0000875320-21-000009.txt   181670

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20210416.xsd EX-101.SCH 2508
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrtx-20210416_cal.xml EX-101.CAL 795
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrtx-20210416_def.xml EX-101.DEF 1759
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20210416_lab.xml EX-101.LAB 24275
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20210416_pre.xml EX-101.PRE 12731
7 EXTRACTED XBRL INSTANCE DOCUMENT vrtx-20210416_htm.xml XML 10599
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19319 | Film No.: 21836329
SIC: 2834 Pharmaceutical Preparations